“Janssen noted [in its SCOTUS petition] that it could be liable for excise taxes approaching $600 million per day… while BMS feared facing up to $1 billion per day in liability.” AstraZeneca’s cert ...
The USPTO today held its third PTAB Listening Session, this one focused on Patent Trial and Appeal Board (PTAB) ...
Biotechnology and Pharmaceutical Services Outsourcing Market · GlobeNewswire Inc. The biotechnology and pharmaceutical services outsourcing market is poised for robust growth, expanding from $71.87 ...
Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this ...
You cannot see that decision when the base case and scenario are mashed into one frightening total. The board needs cleaner ...
Pharmaceutical monopolies, patent law, and global health access shaping drug pricing, power, and inequities in the U.S. and ...
Kosloff is a co-chair of a working group with the China Strategy Initiative at the Council on Foreign Relations and a senior fellow at American Economic Liberties Project. China’s rise is happening ...
Company begins operations with a Health Canada-approved treatment for a rare genetic disease more prevalent in certain regions of Quebec MONTREAL, May 5, 2026 /CNW/ - Three pharmaceutical industry ...
Indian industry, led by pharmaceutical companies, shared plans of investing $20.5 billion in the US at the 2026 SelectUSA Investment Summit, reinforcing the growing role of Indian companies as ...
Mr. Siegel, a professor of history at Boston University, recently wrote a book about the global history of painkillers. See more of our coverage in your search results.Encuentra más de nuestra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results